Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
KTTA stock chart
Technical analysisKey statistics
All statistics- Market cap
- $14.82M
- EPS (TTM)
- -$1.59
- Dividend yield
- None
- 52-week range
- 0.281 – 2.06
- Day range
- 0.4402 – 0.4676
- Volume / Avg
- 132.34K / 228.86K
- Beta
- —
- Shares outstanding
- 33.41M
52-week range
KTTA stock today
Pasithea Therapeutics (KTTA) closed at $0.4434 on Oct 7, down 0.81% (-$0.0036), versus the S&P 500's 0.22% decline. At this level, KTTA sits near the bottom of its 52-week range of $0.281 to $2.06: 78.5% below the high, set on Nov 28, 2025 and 57.8% above the low. KTTA is down 65.6% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 45.4%.
Pasithea Therapeutics has posted a net loss over the last twelve months (EPS of -$1.59), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Pasithea Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2021
Pasithea Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| TVRDTvardi Therapeutics Inc. | 1.10 | +1.85% | $14.67M | vs KTTA |
| KPTIKaryopharm Therapeutics Inc. | 0.645 | -0.75% | $14.63M | vs KTTA |
| AEONAEON Biopharma Inc. Class A | 0.3113 | +7.44% | $15.53M | vs KTTA |
| DAREDare Bioscience Inc. | 0.79 | -5.17% | $15.54M | vs KTTA |
| HINDVyome Holdings Inc. | 2.04 | -0.97% | $14.32M | vs KTTA |
| CLRBCellectar Biosciences Inc. | 1.51 | 0.00% | $14.27M | vs KTTA |
| ALLRAllarity Therapeutics Inc. | 0.984 | -0.13% | $15.66M | vs KTTA |
| BFRIBiofrontera Inc. | 0.9354 | +0.36% | $13.89M | vs KTTA |
Indexes, lists and sector
Pasithea Therapeutics stock FAQ
What is Pasithea Therapeutics's stock price today?
KTTA last traded at $0.4434 as of Oct 7, 4:00 PM EDT, down 0.81% on the day. Prices are delayed at least 15 minutes.
Does Pasithea Therapeutics pay a dividend?
No. Pasithea Therapeutics does not currently pay a regular cash dividend.
Has KTTA ever split its stock?
Yes. The most recent KTTA stock split was a 1-for-20 split on Jan 2, 2024.
What is the KTTA 52-week high?
The 52-week high for KTTA is $2.06 and the 52-week low is $0.281. The stock is currently 78.5% below its high.